1. Home
  2. LTRX vs BNR Comparison

LTRX vs BNR Comparison

Compare LTRX & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantronix Inc.

LTRX

Lantronix Inc.

HOLD

Current Price

$5.76

Market Cap

228.3M

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$20.70

Market Cap

233.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRX
BNR
Founded
1989
2014
Country
United States
China
Employees
352
N/A
Industry
Computer Communications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.3M
233.6M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
LTRX
BNR
Price
$5.76
$20.70
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.17
N/A
AVG Volume (30 Days)
460.6K
64.5K
Earning Date
02-05-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$118,294,000.00
$75,749,382.00
Revenue This Year
$4.59
$136.32
Revenue Next Year
$12.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.56
52 Week Low
$1.91
$2.18
52 Week High
$6.75
$24.18

Technical Indicators

Market Signals
Indicator
LTRX
BNR
Relative Strength Index (RSI) 55.27 57.00
Support Level $5.62 $19.49
Resistance Level $5.93 $21.57
Average True Range (ATR) 0.37 1.89
MACD -0.03 0.01
Stochastic Oscillator 44.60 59.13

Price Performance

Historical Comparison
LTRX
BNR

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: